Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) Operating Expenses (2016 - 2025)

Historic Operating Expenses for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to $5.8 million.

  • MediWound's Operating Expenses rose 46.89% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.5 million, marking a year-over-year increase of 3279.35%. This contributed to the annual value of $22.0 million for FY2024, which is 1677.97% up from last year.
  • MediWound's Operating Expenses amounted to $5.8 million in Q3 2025, which was up 46.89% from $7.1 million recorded in Q2 2025.
  • In the past 5 years, MediWound's Operating Expenses ranged from a high of $7.1 million in Q2 2025 and a low of $3.2 million during Q1 2024
  • In the last 5 years, MediWound's Operating Expenses had a median value of $5.1 million in 2021 and averaged $5.1 million.
  • As far as peak fluctuations go, MediWound's Operating Expenses plummeted by 3403.43% in 2023, and later surged by 5183.18% in 2024.
  • Quarter analysis of 5 years shows MediWound's Operating Expenses stood at $5.1 million in 2021, then rose by 19.27% to $6.0 million in 2022, then dropped by 23.56% to $4.6 million in 2023, then soared by 51.83% to $7.0 million in 2024, then dropped by 17.4% to $5.8 million in 2025.
  • Its Operating Expenses was $5.8 million in Q3 2025, compared to $7.1 million in Q2 2025 and $4.7 million in Q1 2025.